News

Two of Europe’s gene therapy pioneers have reported significant progress in the last week, bringing commercial gene therapy products yet closer to reality.

Europe’s small biotechs have leapt to take advantage of the European Medicines Agency’s (EMEA) office for SMEs, according to a review of its first year in operation.

Matching consumer demand with R&D may seem like an obvious starting point for innovation. But it has proven a transient goal for many countries and companies.

UK tax advice in plain English

2006 was a record year for patents covering financial innovations.

The locals may not like him, but were it not for Borat who would pay any attention to a report on Science and Technology in Kazakhstan?

For research investors, 2006 was the year that the European train finally started to leave the station. The new year will tell whether it’s going anywhere worth visiting.